Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

PPH Market Vectors Pharmaceutical ETF

  • Fund Description

    Market Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors U.S., Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 02/11/16

    • 30-Day SEC Yield1

      2.08%
    • Total Net Assets

      $328.0M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.36%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      03/31/2016
  • Fundamentals
    as of 01/31/16

    • Weighted Average Market Cap

      $107.8B
    • Price/Earnings Ratio
      (Last 12 Months)*

      19.49
    • Price/Book Ratio
      (Last 12 Months)*

      3.46
    *A weighted harmonic average is used to calculate this metric. Price/Book Ratio is the price of a security divided by the book value per share of the security. Price/Earnings Ratio is the price of a security divided by the last twelve months earnings per share of the security.
  • Market Capitalization (%)
    as of 01/31/16

    • Capitalization

      % of Net
      Assets ($)
    • Large (>$5.0B)

      99.5%
    • Mid ($1.0 - $5.0B)

      0.3%
    • Small (<$1.0B)

      0.0%
    This breakdown represents what percentage of the ETF's assets represent large/mid/small-sized companies. The market capitalization of an individual, publicly traded company is calculated by multiplying the company's stock price by the total number of its shares outstanding.
  • 3-YR Risk Measures
    as of 01/31/16

    • Beta vs. S&P 500 Index

      0.92
    • Correlation vs. S&P 500 Index

      0.74
    • Volatility (Standard Deviation)

      13.31
    • Sharpe Ratio

      1.10

    Source: Van Eck Global, FactSet.

    Beta is a measure of sensitivity to market movements. Correlation measures the extent of linear association between the ETF performance and the index performance. Volatility is the annualized standard deviation of the ETF's monthly returns. Sharpe ratio measures risk-adjusted return, and represents the ETF's return less the risk free rate divided by the standard deviation.

  • Country Weightings (%) as of 01/31/16

    • Country

      % of Net Assets
    • UNITED STATES

      64.06
    • UNITED KINGDOM

      10.06
    • SWITZERLAND

      6.85
    • FRANCE

      5.21
    • DENMARK

      5.19
    • ISRAEL

      4.45
    • IRELAND

      4.04
    • Other/Cash

      0.13
  • Portfolio Composition (%)
    as of 02/11/16

    • % of Net Assets
    • Stocks

      100.15
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.15
  • Sector Weightings (%) as of 01/31/16

    • Sector

      % of Net Assets
    • Health Care

      99.9
    • Other/Cash

      0.1
  • Currency Exposure (%)
    as of 01/31/16

    • U.S. Dollar

      99.87
    • Other/Cash

      0.13